Catalyst Wire Dossier Catalyst Wire Dossier

NKG2D-CAR-NK92 Cells

NKG2D-CAR-engineered NK-92 cell therapy · Henan Medical University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKG2D-CAR-NK92 Cells, covering 2025-04-10 to 2025-04-10. Get the full timeline:

Most recent: Clinical Trial Update: NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors [Phase 1]

See pricing